Growth Metrics

Cryo Cell International (CCEL) Cash from Investing Activities (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Cash from Investing Activities for 16 consecutive years, with -$289649.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 74.04% to -$289649.0 in Q4 2025 year-over-year; TTM through Nov 2025 was -$975332.0, a 80.0% increase, with the full-year FY2025 number at -$975332.0, up 80.0% from a year prior.
  • Cash from Investing Activities was -$289649.0 for Q4 2025 at Cryo Cell International, down from $1.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.9 million in Q4 2022 to a low of -$11.2 million in Q3 2022.
  • A 5-year average of -$1.8 million and a median of -$1.2 million in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 11378.77% in 2021, then soared 758.4% in 2022.
  • Cryo Cell International's Cash from Investing Activities stood at -$290943.0 in 2021, then skyrocketed by 758.4% to $1.9 million in 2022, then plummeted by 203.45% to -$2.0 million in 2023, then skyrocketed by 43.7% to -$1.1 million in 2024, then soared by 74.04% to -$289649.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Cash from Investing Activities are -$289649.0 (Q4 2025), $1.1 million (Q3 2025), and -$1.5 million (Q2 2025).